Supplier profile
Zentiva Pharma GmbH
Every public-sector award we hold for this supplier, across Germany, from 13 Aug 2014 to 25 Jul 2026.
Awards won
195
all time
Attributed value
€1.7m
172 shared, unvalued
Buyers
27
public bodies
Active
2014–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 57 | not attributable |
| GWQ ServicePlus AG | 26 | not attributable |
| IKK classic | 23 | €1.0m |
| Techniker Krankenkasse | 16 | €1 |
| AOK Baden-Württemberg | 12 | €663k |
| AOK Nordost – Die Gesundheitskasse | 10 | not attributable |
| AOK Bayern – Die Gesundheitskasse | 8 | not attributable |
| AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen; Stabsbereich Recht; Referat Zentrale Vergabestelle | 5 | not attributable |
| Vergabestelle der AOK – Rheinland-Pfalz/Saarland – Die Gesundheitskasse | 5 | not attributable |
| BARMER Beschaffung und Vergabe | 4 | not attributable |
What they win
Awards
Showing 26–50 of 195 awards we hold
- DAK-G/KKH Wirkstoff Amifampridin ATC WHO: N07XX05 ↗Kaufmännische Krankenkasse - KKH€0awarded 19 Dec 2025
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026 ↗PBMG eGawarded 15 Dec 2025
- Germany – Pharmaceutical products – Generika-Ersatzkassen 27 ↗DAK-Gesundheitshared awardawarded 1 Dec 2025
- 101 - DAK / KKH - Axitinib - L01EK01 ↗DAK-Gesundheitshared awardawarded 1 Dec 2025
- Dienogest und Estradiolvalerat - TK, hkk, HEK (ATC-Code: G03FA15) ↗Techniker Krankenkasseshared awardawarded 7 Oct 2025
- Amantadin FTA - TK, hkk, HEK (ATC-Code: N04BB01) ↗Techniker Krankenkasseshared awardawarded 6 Oct 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teriflunomid, ATC L04AK02 für die Zeit 01.10.2025 - 31.12.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Oct 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Hydrocortison (ausschl Dafo TAB), ATC H02AB09 f.d.Z. 01.10.25-30.09.27 (zzgl.Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Oct 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ticagrelor, ATC B01AC24 für die Zeit 01.06.2025 - 31.05.2027 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Oct 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dimethylfumarat (ausschl 240mg, N3), ATC L04AX07 f.d.Z. 01.10.25-30.09.27 (zzgl.Verlängerung 1x12 Mon) ↗DAK-Gesundheitshared awardawarded 2 Oct 2025
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Hydrocortison (ausschl Dafo TAB), ATC H02AB09 f.d.Z. 01.10.25-30.09.27 (zzgl.Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Oct 2025
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teriflunomid, ATC L04AK02 für die Zeit 01.10.2025 - 31.12.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Oct 2025
- Germany – Pharmaceutical products – Generika Umweltfokus Nr. 1 (Bekanntmachung vergebener Aufträge) ↗Techniker Krankenkasseshared awardawarded 25 Sept 2025
- Germany – Pharmaceutical products – Ersatzkassen-Generika Nr. 25 (Bekanntmachung vergebener Aufträge) ↗Techniker Krankenkasseshared awardawarded 20 Sept 2025
- Germany – Pharmaceutical products – Abschluss von Rabattverträgen gemäß § 130a Abs. 8 SGB V für Arzneimittel im generischen Markt ↗AOK Baden-Württembergshared awardawarded 5 Aug 2025
- Anastrozol ↗AOK Baden-Württembergshared awardawarded 4 Aug 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Colchicin, ATC M04AC01 für die Zeit 01.08.2025 - 31.07.2027 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Aug 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nilotinib (ausgenommen als DISP in Apfelmus) f. d. Z. 01.8.25 - 31.7.27 (zzgl. Verlängerungsoption 1x12 Mon.) ↗DAK-Gesundheitshared awardawarded 2 Aug 2025
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Colchicin, ATC M04AC01 für die Zeit 01.08.2025 - 31.07.2027 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Aug 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 1 Aug 2025
- Germany – Pharmaceutical products – Arzneimittelausschreibung 2025_vergebene Aufträge ↗IKK classicshared awardawarded 19 Jul 2025
- 001 | Abirateron Filmtabletten [3] ↗IKK classic€384kawarded 18 Jul 2025
- Germany – Pharmaceutical products – 33. Generikaausschreibung (2;3er) Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2025
- Bimatoprost + Timolol (MDO) ↗GWQ ServicePlus AGshared awardawarded 7 Jul 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Denosumab, ATC M05BX04 für die Zeit 01.07.2025 - 30.06.2026 (zzgl. Verlängerungsoption 1x 12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Jul 2025
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.